Discover the latest KitoZyme’s innovation to treat constipation at booth I61 at Vitafoods

23-Apr-2018

Already recognised as one of the leaders in weight management, KitoZyme keeps focusing on microbiota and digestive health with a new product to treat constipation, based on an exclusive and patented prebiotic technology

Top: TransiBiota pack, Bottom: Kioslim tabs

Top: TransiBiota pack, Bottom: Kioslim tabs

TransiBiota is a class IIa medical device intended to be used in the:

  • treatment of constipation
  • promotion of regular transit
  • restoration of a balanced microbiota, and
  • relief of gastro-intestinal symptoms related to constipation and/or gut dysbiosis.

63% feel an improvement of constipation symptoms after 4-7 days

But the weight management is not deserted so far since the success of KiOslim led KitoZyme to propose a new galenic form to improve the compliance and recruit new consumers with a film- coated tablet version of KiOslim.

KiOslim is a class IIb medical device having the most complete action for losing weight:

  • reduces availability of carbohydrates for absorption
  • lowers fat intake from diet, and
  • reduces appetite for preventing excessive eating and cravings.

40% more efficient than a diet alone

Discover the latest KitoZyme’s innovation to treat constipation at booth I61 at Vitafoods

Furthermore, KitoZyme presents its truly new end-consumer brand YAW – You Are Wonderful. A range of natural products for well-being (www.yaw.fr).

To find out more about KitoZyme’s products, please contact info@kitozyme.com to arrange a meeting or visit our booth I61 (Awex Pavilion) on Vitafoods Geneva.

Sign up for your free email newsletter

Companies